+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Skin Biopsy Device Market by Device Type (Excisional Biopsy, Incisional Biopsy, Punch Biopsy), End User (Clinics, Dermatology Centers, Hospitals), Clinical Application, Technological Innovation, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6160942
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The skin biopsy device sector sits at the intersection of clinical necessity and technological evolution, delivering essential tools for accurate dermatological diagnosis and research. As patient-centered care and precision medicine gain prominence, clinicians demand biopsy solutions that combine safety, reliability and minimally invasive techniques. This dynamic environment is further influenced by regulatory frameworks, reimbursement policies and evolving clinical protocols, which collectively shape device design and deployment. Across outpatient clinics, hospitals and research laboratories, efficiency, patient comfort and diagnostic accuracy drive procurement decisions. Simultaneously, manufacturers vie to differentiate through technological innovation, integration with digital platforms and strategic partnerships. This introduction outlines how converging clinical demands, technological advances and market drivers position skin biopsy devices as a pivotal component in modern healthcare delivery.

Transformative Technological Shifts Reshaping Clinical Workflows

Over the past decade, the skin biopsy device arena has undergone transformative shifts driven by cutting-edge engineering and shifting care models. Automated systems now streamline workflows, reducing operator variability and enhancing sample consistency. Minimally invasive techniques have redefined patient experience, cutting procedure times and post-procedure complications. Precision imaging integration enables real-time visualization, improving targeting accuracy for complex lesions. Meanwhile, smart device integration-with embedded data analytics and remote monitoring-ushers in proactive care paradigms, enabling clinicians to track healing trajectories and optimize follow-up interventions. These shifts are underpinned by an increased emphasis on interconnectivity: biopsy instruments now form part of broader digital ecosystems that consolidate patient data, pathology results and imaging studies. In parallel, collaborative research between academic centers and device manufacturers fuels iterative improvements, ensuring that next-generation platforms address unmet clinical needs. Collectively, these developments propel the market toward greater automation, patient safety and diagnostic precision, setting new benchmarks for device performance and clinical outcomes.

Navigating the Cumulative Impact of 2025 US Tariffs on Device Cost Structures

The imposition of new tariffs in the United States during 2025 has created significant headwinds for devices and components sourced from key trading partners. Increased duties on imported metals and precision instrumentation have elevated input costs, prompting manufacturers to reassess supply chain configurations. Many are shifting assembly operations closer to domestic manufacturing hubs or renegotiating supplier agreements to mitigate the financial burden. Clinicians, in turn, face the prospect of higher acquisition costs for advanced biopsy platforms, potentially slowing adoption rates for premium automated or imaging-integrated systems. To preserve margins, device producers are exploring design optimizations that reduce reliance on tariff-affected components or seeking tariff exemptions for critical medical grade materials. Additionally, some have diversified procurement across multiple geographies, balancing cost pressures with quality assurance. Ultimately, the cumulative impact of these tariffs underscores the importance of supply chain resilience and strategic sourcing to maintain accessibility to cutting-edge biopsy solutions without compromising performance or affordability.

Key Segmentation Insights Across Device Types, End Users, Applications, Technology and Channels

Insight into device type segmentation reveals that excisional biopsy instruments, encompassing both standard excisional and wide excisional variants, command a significant share of procedural preferences due to their comprehensive tissue retrieval capabilities. Incisional biopsy tools maintain relevance for partial lesion sampling, while punch and shave biopsy devices remain indispensable for dermatology clinics seeking rapid, minimally invasive diagnostics. In the end-user spectrum, hospitals-across specialty and teaching facilities-frequently deploy a diverse array of biopsy instruments to accommodate varied clinical case mixes, whereas dermatology centers and research laboratories emphasize precision and adaptability to support both patient care and investigative protocols. From a clinical application perspective, diagnostic evaluation and pathological analysis dominate utilization, with academic and pharmaceutical studies driving demand under clinical research. Therapeutic monitoring also gains traction as targeted treatments require serial sampling. On the technological front, minimally invasive techniques continue to attract investment, yet automated systems paired with precision imaging are rapidly ascending, and smart device integration-which leverages data analytics and remote monitoring-secures its place in future-ready portfolios. Finally, distribution channels span direct sales, distributor networks, OEM collaborations and online platforms, creating multilayered pathways to reach end users; direct engagements allow for tailored service contracts, distributor relationships extend geographic penetration, OEM agreements foster co-innovation, and online avenues accelerate small-volume procurement. These interwoven segmentation dynamics guide strategic decisions across product development, market entry and lifecycle management.

Key Regional Insights Highlighting Growth Drivers and Adoption Patterns

Regional dynamics vary significantly across the Americas, Europe, Middle East & Africa (EMEA) and Asia-Pacific landscapes. In the Americas, robust healthcare infrastructure, well-established reimbursement frameworks and a strong emphasis on early melanoma detection underpin widespread adoption of advanced biopsy devices. Research cohorts in North America also drive demand for automated sampling and imaging-enhanced platforms. Within EMEA, heterogeneous regulatory regimes and differing public health priorities shape uptake; Western European nations demonstrate high preference for minimally invasive and smart-integrated solutions, while Middle Eastern centers focus on expanding dermatology service capacity, and select African markets prioritize cost-effective punch and shave biopsy devices. In Asia-Pacific, accelerating investments in healthcare modernization fuel growth in urban centers across China, Japan and Australia, where precision imaging integration and data-driven capabilities are particularly prized. Simultaneously, emerging Asia-Pacific markets balance growth with affordability, making modular and adaptable product lines critical for capturing share. These regional nuances inform tailored product roadmaps and regulatory engagement strategies.

Key Company Insights Revealing Strategic Approaches and Innovation Imperatives

Leading companies exhibit diverse strategic approaches to maintain competitive advantage. Global conglomerates such as 3M Company, Abbott Laboratories and Johnson & Johnson leverage their broad portfolios and integrated service offerings to cross-sell biopsy solutions alongside diagnostic platforms. Specialty device manufacturers like Bard Medical, Boston Scientific Corporation and Cook Medical concentrate on niche applications, refining punch and shave technologies for specific clinical settings. Multinational imaging and systems firms-including Canon Medical Systems Corporation, GE Healthcare Inc., Hitachi, Ltd., Siemens Healthineers AG and Philips Healthcare-drive convergence between biopsy instruments and advanced visualization. In contrast, agile innovators such as NeuroMetrix, Inc., Edan Instruments Inc. and Varian Medical Systems pursue data-centric models, embedding analytics and remote monitoring capabilities. Partnerships and OEM collaborations are prominent among organizations such as ConvaTec Group PLC, Hologic Inc., Medtronic Inc. and Smith & Nephew plc, enabling rapid expansion into adjacent therapeutic areas. Meanwhile, traditional optics leaders including Nikon Corporation, Olympus Corporation and Shimadzu Corporation enhance precision imaging integration for dermatological applications. Mid-sized players like Elekta AB, Mindray Medical International Limited, Roper Medical, Inc., Stryker Corporation and Terumo Corporation innovate around modular design and portable platforms, targeting ambulatory clinics and research laboratories. This competitive tapestry emphasizes the importance of cross-sector collaboration, targeted innovation and strategic alliances to navigate evolving clinical demands and regulatory landscapes.

Actionable Recommendations for Industry Leaders to Drive Competitive Advantage

Leaders in the skin biopsy device sector should prioritize supply chain flexibility by diversifying procurement across tariff-exposed and domestic sources, ensuring uninterrupted access to critical materials. Investing in modular platform design will allow rapid adaptation to varied end-user requirements, from outpatient clinics to large teaching hospitals. Strengthening digital integration-through embedded analytics and remote monitoring-will differentiate offerings, enhance post-procedure oversight and create recurring revenue streams via software services. Strategic partnerships with pathology labs and imaging firms can generate end-to-end diagnostic ecosystems, improving clinician satisfaction and patient outcomes. Additionally, targeting underserved regions within EMEA and Asia-Pacific with cost-tailored devices can unlock incremental demand. To sustain innovation pipelines, firms should engage in co-development agreements with academic research centers and pharmaceutical sponsors, aligning next-generation products with emerging clinical trial needs. Finally, transparent engagement with regulatory bodies and payers will expedite approval and reimbursement processes, ensuring timely market access for novel biopsy solutions.

Conclusion: Aligning Strategy with Clinical and Market Realities

The skin biopsy device market stands at a pivotal juncture, shaped by technological breakthroughs, regional diversity and shifting regulatory contexts. Manufacturers that embrace smart integration, modular design and strategic sourcing will be best positioned to meet evolving clinical expectations and navigate the financial implications of trade policies. Collaborative engagement across the value chain-from R&D partnerships to OEM alliances-will unlock synergies that accelerate product innovation and market penetration. As healthcare systems worldwide emphasize precision medicine and patient safety, biopsy instrument providers have a unique opportunity to redefine procedural standards and support improved diagnostic workflows. By aligning strategic priorities with the nuanced demands of different end users and regions, organizations can sustain growth trajectories while delivering tangible clinical value.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Device Type
    • Excisional Biopsy
      • Standard Excisional
      • Wide Excisional
    • Incisional Biopsy
    • Punch Biopsy
    • Shave Biopsy
  • End User
    • Clinics
    • Dermatology Centers
    • Hospitals
      • Specialty Hospitals
      • Teaching Hospitals
    • Research Laboratories
  • Clinical Application
    • Clinical Research
      • Academic Studies
      • Pharmaceutical Studies
    • Diagnostic Evaluation
    • Pathological Analysis
    • Therapeutic Monitoring
  • Technological Innovation
    • Automated Systems
    • Minimally Invasive Techniques
    • Precision Imaging
    • Smart Device Integration
      • Data Analytics
      • Remote Monitoring
  • Distribution Channel
    • Direct Sales
    • Distributor Networks
    • Oem Collaborations
    • Online Platforms
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • 3M Company
  • Abbott Laboratories
  • Bard Medical
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • ConvaTec Group PLC
  • Cook Medical
  • Edan Instruments Inc.
  • Elekta AB
  • Fujifilm Holdings Corporation
  • GE Healthcare Inc.
  • Hitachi, Ltd.
  • Hologic Inc.
  • Johnson & Johnson
  • Karl Storz GmbH & Co. KG
  • Medtronic Inc.
  • Mindray Medical International Limited
  • Mitsubishi Electric Corporation
  • NeuroMetrix, Inc.
  • Nikon Corporation
  • Olympus Corporation
  • Philips Healthcare
  • Roper Medical, Inc.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Terumo Corporation
  • Varian Medical Systems

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Skin Biopsy Device Market, by Device Type
8.1. Introduction
8.2. Excisional Biopsy
8.2.1. Standard Excisional
8.2.2. Wide Excisional
8.3. Incisional Biopsy
8.4. Punch Biopsy
8.5. Shave Biopsy
9. Skin Biopsy Device Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Dermatology Centers
9.4. Hospitals
9.4.1. Specialty Hospitals
9.4.2. Teaching Hospitals
9.5. Research Laboratories
10. Skin Biopsy Device Market, by Clinical Application
10.1. Introduction
10.2. Clinical Research
10.2.1. Academic Studies
10.2.2. Pharmaceutical Studies
10.3. Diagnostic Evaluation
10.4. Pathological Analysis
10.5. Therapeutic Monitoring
11. Skin Biopsy Device Market, by Technological Innovation
11.1. Introduction
11.2. Automated Systems
11.3. Minimally Invasive Techniques
11.4. Precision Imaging
11.5. Smart Device Integration
11.5.1. Data Analytics
11.5.2. Remote Monitoring
12. Skin Biopsy Device Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributor Networks
12.4. Oem Collaborations
12.5. Online Platforms
13. Americas Skin Biopsy Device Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Skin Biopsy Device Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Skin Biopsy Device Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. 3M Company
16.3.2. Abbott Laboratories
16.3.3. Bard Medical
16.3.4. Becton Dickinson and Company
16.3.5. Boston Scientific Corporation
16.3.6. Canon Medical Systems Corporation
16.3.7. ConvaTec Group PLC
16.3.8. Cook Medical
16.3.9. Edan Instruments Inc.
16.3.10. Elekta AB
16.3.11. Fujifilm Holdings Corporation
16.3.12. GE Healthcare Inc.
16.3.13. Hitachi, Ltd.
16.3.14. Hologic Inc.
16.3.15. Johnson & Johnson
16.3.16. Karl Storz GmbH & Co. KG
16.3.17. Medtronic Inc.
16.3.18. Mindray Medical International Limited
16.3.19. Mitsubishi Electric Corporation
16.3.20. NeuroMetrix, Inc.
16.3.21. Nikon Corporation
16.3.22. Olympus Corporation
16.3.23. Philips Healthcare
16.3.24. Roper Medical, Inc.
16.3.25. Shimadzu Corporation
16.3.26. Siemens Healthineers AG
16.3.27. Smith & Nephew plc
16.3.28. Stryker Corporation
16.3.29. Terumo Corporation
16.3.30. Varian Medical Systems
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SKIN BIOPSY DEVICE MARKET MULTI-CURRENCY
FIGURE 2. SKIN BIOPSY DEVICE MARKET MULTI-LANGUAGE
FIGURE 3. SKIN BIOPSY DEVICE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SKIN BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SKIN BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SKIN BIOPSY DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SKIN BIOPSY DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SKIN BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SKIN BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SKIN BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SKIN BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SKIN BIOPSY DEVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SKIN BIOPSY DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SKIN BIOPSY DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY STANDARD EXCISIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY WIDE EXCISIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY INCISIONAL BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY PUNCH BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY SHAVE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY DERMATOLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY ACADEMIC STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY PHARMACEUTICAL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY DIAGNOSTIC EVALUATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY PATHOLOGICAL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY MINIMALLY INVASIVE TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY PRECISION IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY DATA ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY REMOTE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTOR NETWORKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY OEM COLLABORATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SKIN BIOPSY DEVICE MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS SKIN BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. CANADA SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 72. CANADA SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 73. CANADA SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. CANADA SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 75. CANADA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. CANADA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 77. CANADA SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 78. CANADA SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 79. CANADA SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. MEXICO SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 81. MEXICO SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 82. MEXICO SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. MEXICO SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. MEXICO SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 86. MEXICO SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 87. MEXICO SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 88. MEXICO SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES SKIN BIOPSY DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC SKIN BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. CHINA SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 119. CHINA SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 120. CHINA SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. CHINA SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 122. CHINA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. CHINA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 124. CHINA SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 125. CHINA SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 126. CHINA SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. INDIA SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 128. INDIA SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 129. INDIA SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. INDIA SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 131. INDIA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. INDIA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 133. INDIA SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 134. INDIA SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 135. INDIA SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. JAPAN SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 146. JAPAN SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 147. JAPAN SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. JAPAN SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 149. JAPAN SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. JAPAN SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 151. JAPAN SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 152. JAPAN SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 153. JAPAN SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. MALAYSIA SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. PHILIPPINES SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 164. PHILIPPINES SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 165. PHILIPPINES SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. SINGAPORE SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 173. SINGAPORE SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 174. SINGAPORE SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. SOUTH KOREA SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 182. SOUTH KOREA SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 183. SOUTH KOREA SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 189. SOUTH KOREA SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. TAIWAN SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. THAILAND SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 200. THAILAND SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 201. THAILAND SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. THAILAND SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 203. THAILAND SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. THAILAND SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 205. THAILAND SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 206. THAILAND SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 207. THAILAND SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. VIETNAM SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 209. VIETNAM SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 210. VIETNAM SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 214. VIETNAM SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 216. VIETNAM SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA SKIN BIOPSY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 227. DENMARK SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 228. DENMARK SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 229. DENMARK SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. DENMARK SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 231. DENMARK SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. DENMARK SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 233. DENMARK SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 234. DENMARK SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 235. DENMARK SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. EGYPT SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 237. EGYPT SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 238. EGYPT SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. EGYPT SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 240. EGYPT SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. EGYPT SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 242. EGYPT SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 243. EGYPT SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 244. EGYPT SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. FINLAND SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 246. FINLAND SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 247. FINLAND SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. FINLAND SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 249. FINLAND SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. FINLAND SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 251. FINLAND SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 252. FINLAND SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 253. FINLAND SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. FRANCE SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 255. FRANCE SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 256. FRANCE SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. FRANCE SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 258. FRANCE SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. FRANCE SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 260. FRANCE SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 261. FRANCE SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 262. FRANCE SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. GERMANY SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 264. GERMANY SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 265. GERMANY SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. GERMANY SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 267. GERMANY SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. GERMANY SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 269. GERMANY SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 270. GERMANY SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 271. GERMANY SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 279. ISRAEL SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 280. ISRAEL SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. ITALY SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 282. ITALY SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 283. ITALY SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. ITALY SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 285. ITALY SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. ITALY SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 287. ITALY SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 288. ITALY SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 289. ITALY SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 296. NETHERLANDS SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 298. NETHERLANDS SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. NIGERIA SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 300. NIGERIA SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 301. NIGERIA SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. NORWAY SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 309. NORWAY SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 310. NORWAY SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. NORWAY SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 312. NORWAY SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. NORWAY SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 314. NORWAY SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 315. NORWAY SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 316. NORWAY SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. POLAND SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 318. POLAND SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 319. POLAND SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. POLAND SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 321. POLAND SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. POLAND SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 323. POLAND SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 324. POLAND SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 325. POLAND SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 326. QATAR SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 327. QATAR SKIN BIOPSY DEVICE MARKET SIZE, BY EXCISIONAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 328. QATAR SKIN BIOPSY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 329. QATAR SKIN BIOPSY DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 330. QATAR SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 331. QATAR SKIN BIOPSY DEVICE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
TABLE 332. QATAR SKIN BIOPSY DEVICE MARKET SIZE, BY TECHNOLOGICAL INNOVATION, 2018-2030 (USD MILLION)
TABLE 333. QATAR SKIN BIOPSY DEVICE MARKET SIZE, BY SMART DEVICE INTEGRATION, 2018-2030 (USD MILLION)
TABLE 334. QATAR SKIN BIOPSY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 335. RUSSIA SKIN BIOPSY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 336. RUSSIA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Skin Biopsy Device market report include:
  • 3M Company
  • Abbott Laboratories
  • Bard Medical
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • ConvaTec Group PLC
  • Cook Medical
  • Edan Instruments Inc.
  • Elekta AB
  • Fujifilm Holdings Corporation
  • GE Healthcare Inc.
  • Hitachi, Ltd.
  • Hologic Inc.
  • Johnson & Johnson
  • Karl Storz GmbH & Co. KG
  • Medtronic Inc.
  • Mindray Medical International Limited
  • Mitsubishi Electric Corporation
  • NeuroMetrix, Inc.
  • Nikon Corporation
  • Olympus Corporation
  • Philips Healthcare
  • Roper Medical, Inc.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Terumo Corporation
  • Varian Medical Systems